US2017232034A1PendingUtilityA1

Method to alleviate joint pain using low molecular weight hyaluronic acid and joint care components, including type ii collagen

63
Assignee: U S NUTRACEUTICALS LLC D/B/A VALENSA INTPriority: Jul 23, 2009Filed: May 3, 2017Published: Aug 17, 2017
Est. expiryJul 23, 2029(~3 yrs left)· nominal 20-yr term from priority
Inventors:John A. MinatelliW. Stephen HillRudi E. Moerck
A61K 9/4858A23L 33/115A61K 31/726A61K 38/39A61K 35/612A61K 31/685A61K 31/728A61K 36/05A23V 2002/00A61K 31/7008A61K 35/60A23L 33/12A61K 33/22A61K 31/7028A61K 9/0053A61K 31/122A61K 31/202A61K 45/06A61K 36/9066A23L 33/10A61K 35/32A61K 36/324
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain. The composition includes pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments and glucosamine in an oral dosage form.

Claims

exact text as granted — not AI-modified
That which is claimed is: 
     
         1 . A method to treat and alleviate symptoms of joint pain in a person having joint pain by administering to the person a therapeutic amount of a dietary supplement composition comprising pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa), Type II collagen, glucosamine and chondroitin in an oral dosage form. 
     
     
         2 . The method according to  claim 1 , wherein the composition further comprises micro- or nano-dispersed pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments. 
     
     
         3 . The method according to  claim 1 , wherein the glucosamine comprises glucosamine hydrochloride (HCL). 
     
     
         4 . The method according to  claim 1 , wherein the glucosamine comprises glucosamine sulfate. 
     
     
         5 . The method according to  claim 1 , wherein the composition further comprises an anti-inflammatory or joint health promoting compound that is any one of chondroitin, Bowellia, turmeric, methylsulfonymethane (MSM), or s-adenosyl-methionine. 
     
     
         6 . The method according to  claim 1 , further comprising astaxanthin. 
     
     
         7 . A method to treat and alleviate symptoms of joint pain in a person having joint pain by administering to the person a therapeutic amount of a dietary supplement composition comprising pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa), glucosamine and Type II collagen in an oral dosage form. 
     
     
         8 . The method according to  claim 7 , wherein the composition further comprises micro- or nano-dispersed pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments. 
     
     
         9 . The method according to  claim 7 , wherein the glucosamine comprises glucosamine hydrochloride (HCL). 
     
     
         10 . The method according to  claim 7 , wherein the glucosamine comprises glucosamine sulfate. 
     
     
         11 . The method according to  claim 7 , further comprising an anti-inflammatory or joint health promoting compound that is any one of chondroitin, Bowellia, turmeric, methylsulfonymethane (MSM) or s-adenosyl-methionine. 
     
     
         12 . The method according to  claim 7 , further comprising astaxanthin. 
     
     
         13 . A method to treat and alleviate symptoms of joint pain in a person having joint pain by administering to the person a therapeutic amount of a dietary supplement composition comprising pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) and Type II collagen in an oral dosage form. 
     
     
         14 . The method according to  claim 13 , wherein the composition comprises micro- or nano-dispersed pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments. 
     
     
         15 . The method according to  claim 13 , further comprising an anti-inflammatory or joint health promoting compound that is any one of chondroitin, Bowellia, turmeric, methylsulfonymethane (MSM) or s-adenosyl-methionine. 
     
     
         16 . The method according to  claim 13 , wherein the Type II collagen comprises a chicken sternal cartilage derived collagen. 
     
     
         17 . The method according to  claim 13 , wherein the Type II collagen comprises a bovine derived collagen. 
     
     
         18 . The method according to  claim 13 , further comprising astaxanthin.

Join the waitlist — get patent alerts

Track US2017232034A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.